Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$826,816,350
-$72,202,681 QoQ
Shares Held
3,255,567
-11.5% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#73
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 33%
None 67%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,379,567,692 across 14 Drug Manufacturers - General names. JNJ ranks #3 (18.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,190,792 | $1,428,271,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,484,756 | $833,291,145 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
3,255,567 | $826,816,350 | |
| 4 | ABBV |
AbbVie Inc.
|
2,374,888 | $597,616,815 | |
| 5 | AZN |
Astrazeneca PLC
|
1,233,595 | $233,914,282 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,845,511 | $233,161,858 | |
| 7 | AMGN |
Amgen Inc
|
195,409 | $70,761,506 | |
| 8 | BIIB |
Biogen Inc.
|
246,782 | $53,319,718 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $826,816,350 | 3,255,567 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $899,019,031 | 3,677,872 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $186,543,281 | 901,393 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $182,643,149 | 985,024 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $121,580,292 | 795,943 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $130,379,095 | 786,174 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $113,293,427 | 783,387 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $131,035,233 | 808,560 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $158,724,935 | 1,085,967 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $183,475,405 | 1,159,842 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $278,154,251 | 1,774,622 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $272,608,290 | 1,750,294 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $320,959,996 | 1,939,101 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $211,886,395 | 1,367,009 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $257,642,611 | 1,458,492 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $238,456,591 | 1,459,700 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $322,683,890 | 1,817,835 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $336,139,202 | 1,896,627 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $321,077,518 | 1,876,878 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $456,913,377 | 2,829,185 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $472,663,439 | 2,869,148 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $354,328,738 | 2,155,940 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $342,450,066 | 2,175,944 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $346,579,239 | 2,327,910 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $338,090,269 | 2,404,112 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $372,983,548 | 2,844,380 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||